Fusion Pharmaceuticals Inc. Gains 99.06%
Tue, Mar 19, 2024 at 07:28 PM
Fusion Pharmaceuticals Inc. (FUSN:NASDAQ) jumped higher at $21.18, representing a gain of 99.1%. On Tue, Mar 19, 2024, FUSN:NASDAQ touched a New 2-Week High of $21.18. The stock got featured on our News Catalysts scanner on Tue, Mar 19, 2024 at 02:38 PM in the 'ACQUISITION' category. From Tue, Mar 05, 2024, the stock recorded 70.00% Up Days and 54.55% Green Days
About Fusion Pharmaceuticals Inc. (FUSN:NASDAQ)
Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer.
Top 10 Gainers:
- Ontrak Inc. (OTRK:NASDAQ), 131.58%
- Fusion Pharmaceuticals Inc. (FUSN:NASDAQ), 99.06%
- SCWorx Corp. (WORX:NASDAQ), 53.51%
- Sarcos Technology and Robotics Corporation (STRC:NASDAQ), 40.38%
- Enliven Therapeutics Inc Com (ELVN:NASDAQ), 38.77%
- Puyi Inc. (PUYI:NASDAQ), 33.93%
- BitFuFu Inc. (FUFU:NASDAQ), 32.35%
- Critical Metals Corp. (CRML:NASDAQ), 31.04%
- Vincerx Pharma Inc. (VINC:NASDAQ), 28.31%
- Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT), 25.54%